World World Urological Oncology Federation Urological Oncology International Health Issues in Urological Oncology Federation Vancouver, BC | September 8, 2013 Vancouver Convention Centre | Room Number 211 agenda WELCOME & INTRODUCTIONS 8:00 Chairman's Welcome & Framing of Theme: 'International Issues in Men's Health' | Laurence Klotz, MD | CANADA 8:05 SESSION ONE | PROSTATE CANCER: ADVANCED & CASTRATE RESISTANT | Moderator: Thomas Keane, MD | USA 8:10 Autophagy in Prostate Cancer | Christopher Evans, MD | USA 8:25 Check-Point Regulators and Prostate Cancer Progression | Robert Siemens, MD | CANADA 8:40 Lessons From In-Vivo Models of Castration-Resistant Prostate Cancer | Daniel Lin, MD | USA 8:55 Evolving Treatment Landscape in CRPC and Approaches to Co-Targeting Adaptive Survival Pathways | Martin Gleave, MD | CANADA 9:10 DISCUSSION (15 MIN) 9:25 BREAK 9:40 SESSION TWO | KIDNEY CANCER: NEW CONCEPTS IN LOCAL AND SYSTEMIC THERAPY | Moderator: Hirotsugo Uemura, MD | JAPAN 9:45 WUOF SPECIAL GUEST LECTURE: Georg Bjarnason, MD | CANADA Improved Outcomes in RCC Patients Treated with an Individualized Sunitinib Dose and Schedule 10:05 DISCUSSION (5 MIN) 10:10 Molecular Imaging in RCC | Damien Bolton, MD | AUSTRALIA 10:25 Personalizing the Care of Early Stage RCC | Michael Jewett, MD | CANADA 10:40 Partial vs Radical for T1-2 RCC: Tempest in a Teapot? | Mark Frydenberg, MD | AUSTRALIA 10:55 Causes and Consequences of Micro RNA Dysregulation in RCC | Susanne Osanto, MD | THE NETHERLANDS 11:10 Targeted Neoadjuvant and Adjuvant Therapy for RCC | Yoshihiko Tomita, MD | JAPAN 11:25 Integration of Surgery, Ablation and RT in the Management of Advanced RC | Antonio Finelli, MD | CANADA 11:40 DISCUSSION (15 MIN) 11:55 BREAK & LUNCH SERVICE: (All Attendees: pick up lunch and return to seats for the Working Lunch Session) WORKING LUNCH (All Attendees) Laurence Klotz, MD | CANADA 12:15 SESSION THREE | TOWN HALL FORUM ON BLADDER CANCER RISK REDUCTION | Co-Moderators: Badrinath Konety, MD | USA Introduction of Global Panel and Concept | Laurence Klotz, MD | CANADA 12:20 Evidence Based Tobacco Dependence Treatment | Milan Khara, MD | CANADA 12:40 Smoking Cessation in Europe | Roman Sosnowski, MD | POLAND 12:55 Evolution of Bladder Cancer in Egypt | Hassan Abol-Enein, MD | EGYPT 1:10 Men's Health and Smoking Cessation | Larry Goldenberg, MD | CANADA 1:25 WUOF Bladder Cancer Prevention Project | Maurizio Brausi, MD | ITALY 1:40 PANEL DISCUSSION & FORUM (25 MIN) (Panelists: Drs. Sosnowski, Abol-Enein, Goldenberg, Brausi and Li) 2:05 SESSION FOUR | BLADDER CANCER | Co-Moderators: Shrawan Singh, MD | INDIA and Michael Droller, MD | USA 2:10 Sex Steroid Sensitivity and Gender Differences in Bladder Cancer | Arnulf Stenzl, MD | GERMANY 2:25 Current Role of PET, CT, MR for Invasive Bladder Cancer | Nathan Lawrentschuk, MD | AUSTRALIA 2:40 Chinese Perspective on the Management of Invasive Bladder Cancer | Ning Chen Li, MD | CHINA 3:05 Variant Histology in Urothelial Carcinoma: Clinical Impact | Shahrokh Shariat, MD | AUSTRIA 3:20 DISCUSSION (10 MIN) 3:30 SESSION FIVE | PROSTATE CANCER LOCALIZED | Moderator: Manfred Wirth, MD | GERMANY 3:35 Screening for Prostate Cancer in the US - A 2013 Perspective | Peter Carroll, MD, MPH | USA 3:50 Is Prostate Cancer Really More Common in Japan Today Than 20 Years Ago? | Shin Egawa, MD | JAPAN 4:05 Management of Prostate Cancer in Sub-Saharan Africa | Serigne Magueye Gueye, MD | SENEGAL 4:20 DISCUSSION (5 MIN) 4:25 Progress in Image Guided Prostate Biopsy | Samir Taneja, MD | USA 4:40 Can MRI Replace Prostate Biopsy? | Arnauld Villers, MD | FRANCE 4:55 Can PCA3 or Other Biomarkers Replace Most Prostate Biopsies? | Peter Mulders, MD | THE NETHERLANDS 5:10 Progress in Focal Therapy | Mark Emberton, MD | ENGLAND 5:25 DISCUSSION (5 MIN) 5:30 Adjourn | Laurence Klotz, MD | CANADA 1055 Canada Place, Vancouver, BC World Urological Oncology Federation International Health Issues in Urological Oncology Vancouver, BC | September 8, 2013 This meeting has been made possible by funding from our sponsors: Steering Committee Member Societies Christopher Cheng, MD Asian-Pacific Society of Urologic Oncology (Singapore) Australian Urologic Oncology Section Mark Frydenberg, MD BAUS-Urologic Oncology Section (Australia) Canadian Uro-Oncology Group Badrinath Konety, MD Chinese Urologic Oncology Group (USA) European Society of Urologic Oncology Laurence Klotz, MD German Society of Urological Oncology (Canada) Indian Urological Society Ning Chen Li, MD Israeli Society of Urologic Oncology (China) Italian Society ofUrologic Oncology Tim O'Brien, MD Japanese Urological Association (UK) Korean Society of Urologic Oncology Shrawan Singh, MD (India) Latin American Society of Urologic Oncology Mexican Society of Uro-Oncology Philippines Society of Urologic Oncology Society of Urologic Oncology (North America) Turkish Urologic Oncology Society Australia Michael Jewett, MD Germany Netherlands Department of Surgical Oncology Damien M Bolton, MD, MBBS, BA, (Urology), Princess Margaret Arnulf Stenzl, MD Peter Mulders, MD, PhD FRCS, FRACS Hospital/University Health Network, Professor and Chairman Professor and Chairman Clinical Professor of Surgery, and Professor, Department of Surgery Deptartment of Urology Dept of Urology Director, Department of Urology, (Urology), University of Toronto University Medical Clinic Tuebingen, Radboud University Medical Centre University of Melbourne, Germany Nijmegen Austin Health Milan Khara, MBChB, CCFP, Director Scientific Office European Dip.ABAM Susanne Osanto, MD, PhD Mark Frydenberg, MD, MBBS, Association of Urology Clinical Director, Smoking Cessation Clinic Professor of Medical Oncology FRACS (Urology) Chairman, Vancouver General Hospital Manfred Wirth, MD Department of Clinical Oncology Professor and Chairman Uro-oncology Special Advisory Group Clinical Assistant Professor, Leiden University Medical Center (LUMC) Department of Urology Urological Society of Australia and Faculty of Medicine The Netherlands University Hospital Carl Gustav Carus New Zealand Associate Professor, University of British Columbia Chair European Uro-Oncology Group (EUOG) Department of Surgery Faculty of Medicine Technical University of Dresden and Health Sciences, Laurence Klotz, MD United States of America Professor of Surgery, University of Toronto India Monash University Chairman, Department Peter Carroll, MD, MPH Chairman, World Urologic Oncology of Urology, Monash Medical Centre Shrawan K. Singh, MS, MCh, FAMS Professor and Chair Federation Chairman, Clinical Institute of Specialty Professor of Urology, Ken and Donna Derr - Chevron Editor Emeritus, Canadian Urologic Surgery, Epworth Healthcare Post Graduate Institute of Medical Distinguished Professor Association Journal Education & Research, Nathan Lawrentschuk, MD, MB BS, Department of Urology, Associate Dean FACULTY & PARTICIPANTS: Chairman, Canadian Urology Chandigarh-160012, India Director of Clinical Services and Strategic PhD, FRACS (Urology) Research Consortium Planning Associate Professor, Division of Urology Italy UCSF - Helen Diller Comprehensive University of Melbourne Sunnybrook Health Sciences Centre Department of Surgery, Maurizio Brausi, MD Cancer Center Austin Hospital D. Robert Siemens, MD, FRCSC Professor and Chairman of Urology University of California, San Francisco Professor and Chair Ausl Modena, Chairman ESOU Michael Droller, MD Austria Department of Urology Chairman Bladder cancer Group SIU Katherine and Clifford Goldsmith Professor Director, Centre of Applied (Italian Society of Urology) Shahrokh F. Shariat, MD of Urology Urological Research Faculty Member ESU Professor and Chairman Professor of Oncology Queen’s University (European School of Urology) Department of Urology The Mount Sinai Medical Center Medical University of Vienna China Japan New York, NY Währinger Gürtel 18-20 Christopher P. Evans, MD, FACS A-1090 Vienna, Austria Ningchen Li, MD Shin Egawa, MD Professor and Vice Director Peking Professor and Chairman, Professor and Chairman, Canada University Wujieping Urology Center No 9, Department of Urology, Department of Urology Jinyuanzhuang Road, Shijingshan District, Jikei University School of Medicine, Urologic Surgical Oncology Georg A. Bjarnason, MD, FRCP(C) Beijing 3-25-8 Nishi-Shimbashi, Minato-ku, University of California, Davis The Anna-Liisa Farquharson Chair Tokyo 105-8461 School of Medicine, Sacramento, CA in Renal Cell Cancer Research Egypt Associate Professor, Faculty of Medicine, Yoshihiko Tomita Thomas E. Keane, MB, ChB, FRCSI, University of Toronto Hassan Abol-Enein, MD, PhD. Professor and Chairman Department of FACS Division of Medical Oncology, Sunnybrook Professor of Urology Urology Yamagata University Faculty of Professor and Chairman Odette Cancer Centre Urology and Nephrology Center Medicine Iida-nish Yamagata Department of Urology Mansoura University Medical University of South Carolina Hirotsugu Uemura, MD, PhD Antonio Finelli, MD, MSc, FRCSC Mansoura Urologic Oncology/ Professor and Chair Department of Urology Badrinath Konety, MD Minimally Invasive Surgery England Kinki University Faculty of Medicine 377-2 Professor and Chair Department of Surgical Oncology Ohno-Higashi, Department of Urology Princess Margaret Hospital (UHN) Mark Emberton, MD, FRCS, Urol Osaka-Sayama Osaka University of Minnesota Professor of Interventional Oncology, UCL Associate Professor, University of Toronto Daniel W. Lin, MD Honorary Consultant Urological Surgeon Poland Chief of Urologic Oncology Martin Gleave, MD, FRCSC, FACS UCH NHS Foundation